Predict your next investment

METALS & MINING
pagetminerals.com

See what CB Insights has to offer

Stage

Acq - Fin | Alive

About Paget Minerals

Paget Minerals focuses on mineral exploration and the advancement of the company's priority Ball Creek Project.In February 2012, Paget Minerals was acquired by Pinetree Capital. The valuation of Paget Minerals was undisclosed. Other terms of the deal were not released.

Paget Minerals Headquarter Location

1130 West Pender Street Suite 1210

V6E 4A4,

United States

778-327-4449

Latest Paget Minerals News

CSE New #Cannabis Stock Listing: Ascent Industries Corp. (ASNT)

Aug 8, 2018

CSE New #Cannabis Stock Listing: Ascent Industries Corp. (ASNT)   August 8, 2018 (Investorideas.com Newswire) The common shares of Ascent Industries Corp., previously listed as Paget Minerals Corp. have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date. In Canada, Ascent (through its wholly-owned subsidiaries) is a Licenced Producer under the Access to Cannabis for Medical Purposes Regulations of Health Canada, with licences to cultivate cannabis and produce cannabis extracts. In addition, the Company is a Licenced Dealer under the Controlled Drugs and Substances Act (Canada), with the ability to produce, package, sell, send, transport and distribute medically focused cannabis products in Canada to other licenced entities and internationally in jurisdictions where medical cannabis is legal. In the United States, the Company holds licences in Oregon (for processing and for distribution of cannabis to any licenced entity in the state) and in Nevada (for cultivation and for production, processing and wholesale distribution of cannabis). In Europe, Agrima ApS, a Danish company and wholly-owned subsidiary of Ascent, has submitted licence applications for a Wholesaler Dealers Licence and Controlled Drug Licence in Denmark, and applications for the approval of eight products to the Danish Medical Cannabis Pilot Program. ________________________ Les actions ordinaires de Ascent Industries Corp., auparavant inscrites à titre de Paget Minerals Corp., ont été approuvées apour inscription à la cote du CSE. Les documents d'inscription et de divulgation seront disponibles sur www.thecse.com à la date de négociation. Au Canada, Ascent (par l'intermédiaire de ses filiales en propriété exclusive) est un producteur autorisé en vertu du Règlement sur l'accès au cannabis à des fins médicales de Santé Canada, avec des licences pour cultiver du cannabis et produire des extraits de cannabis. En outre, la Société est un distributeur agréé en vertu de la Loi réglementant certaines drogues et autres substances (Canada), capable de produire, d’emballer, de vendre, d’envoyer, de transporter et de distribuer des produits du cannabis le cannabis médical est légal. Aux États-Unis, la Société détient des licences en Oregon (pour le traitement et la distribution de cannabis à toute entité autorisée dans l'État) et au Nevada (pour la culture et la production, la transformation et la distribution en gros de cannabis). En Europe, Agrima ApS, une société danoise et filiale à 100% d'Ascent, a présenté des demandes de licence pour une licence de grossiste et une licence contrôlée au Danemark, ainsi que des demandes d'approbation de huit produits au programme pilote danois de cannabis médical. If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com Pour toute question, pour obtenir de l'information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l'adresse: Listings@thecse.com Investorideas.com is a Canadian Securities Exchange (CSE) Service Provider; Cannabis stocks, Blockchain stocks, Mining, E-sports, Energy, Biotech and more...

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.